SPDEF and prostate carcinoma: Given the apparent lack of in vivo data using animal models, we generated several distinct mouse models of prostate cancer with loss-of-function and gain-of-function of SPDEF to demonstrate that SPDEF inhibits prostate carcinogenesis by preventing a positive feedback mechanism regulating the Foxm1 oncogene.